AEMS Corp
AEMS Corp offers automated, microscale formulation screening for injectable biologics. The company maps multicomponent excipient space using combinatorial design and machine learning to identify low-viscosity formulations suitable for subcutaneous delivery.
AEMS Corp offers automated, microscale formulation screening for injectable biologics. The company maps multicomponent excipient space using combinatorial design and machine learning to identify low-viscosity formulations suitable for subcutaneous delivery. Its services span monoclonal antibodies, siRNA and peptides, using only US FDA-approved excipients.
Authors and Contacts
Article
